Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies

Intensive Care Medicine

Volumn 23, Issue 8, 1997, Pages 885-888

  Hirschl, M M ^a   Binder, M ^b   Bur, A ^a   Herkner, H ^a   Mullner M ^a   Woisetschlager C ^a   Laggner, A N ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Hypertensive emergencies; Sodium nitroprusside; Urapidil

Indexed keywords

NITROPRUSSIDE SODIUM; URAPIDIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRADYCARDIA; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; EMERGENCY WARD; FEMALE; FOLLOW UP; HOSPITAL; HOT FLUSH; HUMAN; HYPERTENSION; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; VERTIGO;

ADULT; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; EMERGENCIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NITROPRUSSIDE; PIPERAZINES; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0030760447     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050426     Document Type: Article

References (10)

1. Kaplan NM (1994) Management of hypertensive emergencies. Lancet 344: 1335-1138
2. The Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (1993) Arch Intern Med 153: 154-183
3. Hirschl MM (1995) Guidelines for the drug treatment of hypertensive crises. Drugs 50: 991-1000
4. Aitken D, West D, Smith F, Poznanski W, Cowan J, Hurtig J, Peterson E, Benoit B (1977) Cyanide toxicity following nitroprusside induced hypotension. Can Anaesth Soc J 24: 651-660
5. Cetnarowski AB, Conti DR (1986) Nitroprusside toxicity and low-dose infusion. Ann Intern Med 6: 895-896
6. Robin ED, McCauley R (1992) Nitroprusside-related cyanide poisoning. Time (long past due, for urgent, effective interventions. Chest 102: 1842-1845
7. Nightingale SL (1991) New labeling for sodium nitroprusside emphasizes risk of cyanide toxicity (FDA Bulletin). JAMA 265: 847
8. Patel CB, Laboy V, Venus B, Mathru M, Wier D (1986) Use of sodium nitroprusside in post-coronary bypass surgery. A plea for conservativism. Chest 89: 663-667
9. Michel D (1990) Recognizing and treating hypertensive crises. Etiology-recommendations for therapy by the German Hypertension League. Fortschr Med 108: 18-21
10. Panacek EA, Bednarczyk EM, Dunbar LM, Foulke GE, Holcslaw TL, for the Fenoldapam Study Group (1995) Randomized prospective trial of fenoldapam vs sodium nitroprusside in the treatment of acute severe hypertension. Acad Emerg Med 2: 959-965